ketanserin has been researched along with Brain Diseases in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biver, F | 1 |
| Wikler, D | 1 |
| Lotstra, F | 1 |
| Damhaut, P | 1 |
| Goldman, S | 1 |
| Mendlewicz, J | 1 |
1 other study available for ketanserin and Brain Diseases
| Article | Year |
|---|---|
Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex.
Topics: Brain Diseases; Depressive Disorder; Female; Humans; Ketanserin; Male; Middle Aged; Receptors, Serot | 1997 |